- $15.75m
- $5.70m
2018 June 30th | 2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.001 | 0.405 | 30.3 | 35.5 | 27.2 |
Operating Profit | -0.001 | -0.405 | -30.3 | -35.5 | -27.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.001 | 0.483 | -30.1 | -36.2 | -28.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.001 | 0.347 | -30.1 | -36.2 | -28.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.001 | 0.347 | -30.1 | -36.2 | -28.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.001 | 0.347 | -30.1 | -36.2 | -28.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | 0.174 | -1.3 | -1.39 | -0.949 |
Dividends per Share |